Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for TECX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 237.03M
March 31, 2026 246.58M
December 31, 2025 261.04M
September 30, 2025 277.00M
June 30, 2025 295.31M
March 31, 2025 314.83M
December 31, 2024 152.90M
September 30, 2024 168.72M
June 30, 2024 193.91M
March 31, 2024 92.35M
December 31, 2023 39.40M
September 30, 2023 110.52M
June 30, 2023 133.84M
March 31, 2023 83.00M
December 31, 2022 103.95M
September 30, 2022 129.50M
June 30, 2022 146.24M
March 31, 2022 175.34M
Date Value
December 31, 2021 203.84M
September 30, 2021 216.45M
June 30, 2021 238.10M
March 31, 2021 245.91M
December 31, 2020 271.23M
September 30, 2020 233.26M
June 30, 2020 255.57M
March 31, 2020 269.73M
December 31, 2019 200.51M
September 30, 2019 217.20M
June 30, 2019 101.99M
March 31, 2019 117.37M
December 31, 2018 133.48M
September 30, 2018 143.27M
June 30, 2018 158.73M
March 31, 2018 60.22M
December 31, 2017 7.022M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M
Vericel Corp. 502.87M

Total Assets (Quarterly) Related Metrics